Because helminth infections are extremely uncommon in countries with highly developed CAPS cohorts, it remains to be determined whether NLRP3 activation suppresses type 2 responses to pathogens in humans, as it does in murine models (67–69). The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.